Nanobiotix (NBTX) Invested Capital: 2019-2025

  • Nanobiotix's Invested Capital fell 24.67% to $125.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $125.7 million, marking a year-over-year decrease of 24.67%. This contributed to the annual value of $126.4 million for FY2024, which is 19.09% down from last year.
  • Per Nanobiotix's latest filing, its Invested Capital stood at $125.7 million for Q2 2025, which was down 0.56% from $126.4 million recorded in Q4 2024.
  • In the past 5 years, Nanobiotix's Invested Capital registered a high of $220.9 million during Q2 2021, and its lowest value of $124.0 million during Q2 2023.
  • Its 3-year average for Invested Capital is $139.7 million, with a median of $126.4 million in 2024.
  • As far as peak fluctuations go, Nanobiotix's Invested Capital plummeted by 34.81% in 2022, and later soared by 34.61% in 2024.
  • Nanobiotix's Invested Capital (Quarterly) stood at $169.1 million in 2021, then tumbled by 34.81% to $144.0 million in 2022, then fell by 13.91% to $155.4 million in 2023, then dropped by 18.66% to $126.4 million in 2024, then decreased by 24.67% to $125.7 million in 2025.
  • Its Invested Capital was $125.7 million in Q2 2025, compared to $126.4 million in Q4 2024 and $166.9 million in Q2 2024.